COMPARATIVE STUDY OF THREE BRANDS OF SLIDENAFIL CITRATE TABLETS IN SUDANESE MARKETS

Aim and Objectives: This study assessed the quality of Sildenafil citrate tablet products, whether locally produced or imported, available in the Sudanese market, aiming to determine their potential interchangeability in clinical use. Methods: The quality evaluation of the drug products covered physical and organoleptic characteristics, along with tests for weight variation, friability, hardness, disintegration time, dissolution profile, and determination of Sildenafil content. The assay was performed using the standard HPLC method. Results: Findings indicated that the similarity between brand E & F was noticed in color, shape, film coat and weight, brand E, friability and hardness results were acceptable, the dissolution result showed that the peak release of the drug is between 30-45 minutes, disintegration of the tablet was not faster than brand F but shorter than brand S. Brands E and S were found to be containing more that the assumed concentration of Sildenafil Citrate (50 mg). Conclusion: The finding of this research clearly notes that the range of the active ingredient content in two brands out of the three is obviously way above limits. USP states that the tablet assay range flouts between 90-110%. Sildenafil is now widely prescribed for pulmonary hypertension in children here in Sudan, and it has been used with a high success ratio in this field, so the dosing system should be carefully measured, and without a proper Q.A, Q.C testing of the brands itself, it could lead to a very dangerous consequences. Peer Review History: Received 8 June 2025; Reviewed 11 July 2025; Accepted 20 August; Available online 15 September 2025 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, [email protected] Reviewers: Aya Mohammed Mohammed Essawy, MTI University- Mokattam, Egypt, [email protected] Dina Abd Elfattah Eldakhs, Pharos university (PUA), Egypt, [email protected]

Authors

Institutions

Publication Details

Journal
Universal Journal of Pharmaceutical Research
Published
2025-09-15
DOI
https://doi.org/10.22270/ujpr.v10i4.1387
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COMPARATIVE STUDY OF THREE BRANDS OF SLIDENAFIL CITRATE TABLETS IN SUDANESE MARKETS

Abdrhman Mahmoud Gamil, Mahmoud A. Ibrahim, Abdul Sami, Zuheir Osman et al.
Universal Journal of Pharmaceutical Research
Pharmaceutical Quality and Counterfeiting
article

COMPARATIVE STUDY OF THREE BRANDS OF SLIDENAFIL CITRATE TABLETS IN SUDANESE MARKETS

Abdrhman Mahmoud Gamil, Mahmoud A. Ibrahim, Abdul Sami, Zuheir Osman, Fatehalrahman F. Magbool
article en

Abstract

Aim and Objectives: This study assessed the quality of Sildenafil citrate tablet products, whether locally produced or imported, available in the Sudanese market, aiming to determine their potential interchangeability in clinical use. Methods: The quality evaluation of the drug products covered physical and organoleptic characteristics, along with tests for weight variation, friability, hardness, disintegration time, dissolution profile, and determination of Sildenafil content. The assay was performed using the standard HPLC method. Results: Findings indicated that the similarity between brand E & F was noticed in color, shape, film coat and weight, brand E, friability and hardness results were acceptable, the dissolution result showed that the peak release of the drug is between 30-45 minutes, disintegration of the tablet was not faster than brand F but shorter than brand S. Brands E and S were found to be containing more that the assumed concentration of Sildenafil Citrate (50 mg). Conclusion: The finding of this research clearly notes that the range of the active ingredient content in two brands out of the three is obviously way above limits. USP states that the tablet assay range flouts between 90-110%. Sildenafil is now widely prescribed for pulmonary hypertension in children here in Sudan, and it has been used with a high success ratio in this field, so the dosing system should be carefully measured, and without a proper Q.A, Q.C testing of the brands itself, it could lead to a very dangerous consequences. Peer Review History: Received 8 June 2025; Reviewed 11 July 2025; Accepted 20 August; Available online 15 September 2025 Academic Editor: Dr. A.A. Mgbahurike, University of Port Harcourt, Nigeria, [email protected] Reviewers: Aya Mohammed Mohammed Essawy, MTI University- Mokattam, Egypt, [email protected] Dina Abd Elfattah Eldakhs, Pharos university (PUA), Egypt, [email protected]

Universal Journal of Pharmaceutical Research
University of Khartoum (SD), Al-Neelain University (SD), National Ribat University (SD), National University (SD), Red Sea University (SD)
Openalex Percentile: Top 66%
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.